Swisscanto
Asset management arm of Zürcher Kantonalbank offering private equity funds investing in unlisted Swiss and European growth companies.
Swisscanto was founded in 2018, is headquartered in Zurich, Switzerland, has 3 recorded investments, and includes 3 companies in its recorded portfolio.
- Headquarters
- Zurich, Switzerland
- Founded
- 2018
- Website
- swisscanto.com
- Portfolio Companies
- 3
- Total Investments
- 3
- Last Investment
- May 2024
- Geographic Focus
- Europe, Switzerland
Indexed holds 3 portfolio companies and 3 funding rounds for this investor. The full record is or through the API.
Investment Thesis
Swisscanto is a Venture Capital firm based in Zurich, Switzerland. It was founded in 2018. It has made 3 investments, including 1plusX, NIL Technology and MedTrace Pharma. Focus areas include Clean Tech and Digital Health.
Portfolio3
Co-investors7
Sign up to view co-investors
7 co-investors across 7 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×4 · Corporate VC ×1 · Private Equity ×1 · 5 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/swisscanto"><img src="https://indexed.vc/api/badge/investor/swisscanto" alt="Swisscanto on Indexed.vc" width="260" height="76" /></a>
